- Switzerland
- /
- Chemicals
- /
- SWX:CLN
An Intrinsic Calculation For Clariant AG (VTX:CLN) Suggests It's 50% Undervalued
Key Insights
- The projected fair value for Clariant is CHF25.95 based on 2 Stage Free Cash Flow to Equity
- Current share price of CHF13.10 suggests Clariant is potentially 50% undervalued
- The CHF16.11 analyst price target for CLN is 38% less than our estimate of fair value
Today we will run through one way of estimating the intrinsic value of Clariant AG (VTX:CLN) by taking the expected future cash flows and discounting them to today's value. This will be done using the Discounted Cash Flow (DCF) model. Don't get put off by the jargon, the math behind it is actually quite straightforward.
We would caution that there are many ways of valuing a company and, like the DCF, each technique has advantages and disadvantages in certain scenarios. Anyone interested in learning a bit more about intrinsic value should have a read of the Simply Wall St analysis model.
See our latest analysis for Clariant
Step By Step Through The Calculation
We're using the 2-stage growth model, which simply means we take in account two stages of company's growth. In the initial period the company may have a higher growth rate and the second stage is usually assumed to have a stable growth rate. In the first stage we need to estimate the cash flows to the business over the next ten years. Where possible we use analyst estimates, but when these aren't available we extrapolate the previous free cash flow (FCF) from the last estimate or reported value. We assume companies with shrinking free cash flow will slow their rate of shrinkage, and that companies with growing free cash flow will see their growth rate slow, over this period. We do this to reflect that growth tends to slow more in the early years than it does in later years.
A DCF is all about the idea that a dollar in the future is less valuable than a dollar today, and so the sum of these future cash flows is then discounted to today's value:
10-year free cash flow (FCF) forecast
2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | |
Levered FCF (CHF, Millions) | CHF265.7m | CHF328.5m | CHF336.0m | CHF393.0m | CHF425.5m | CHF450.2m | CHF468.7m | CHF482.2m | CHF492.1m | CHF499.3m |
Growth Rate Estimate Source | Analyst x3 | Analyst x4 | Analyst x2 | Analyst x1 | Est @ 8.27% | Est @ 5.81% | Est @ 4.09% | Est @ 2.89% | Est @ 2.05% | Est @ 1.46% |
Present Value (CHF, Millions) Discounted @ 5.4% | CHF252 | CHF295 | CHF287 | CHF318 | CHF327 | CHF328 | CHF324 | CHF316 | CHF306 | CHF294 |
("Est" = FCF growth rate estimated by Simply Wall St)
Present Value of 10-year Cash Flow (PVCF) = CHF3.0b
After calculating the present value of future cash flows in the initial 10-year period, we need to calculate the Terminal Value, which accounts for all future cash flows beyond the first stage. The Gordon Growth formula is used to calculate Terminal Value at a future annual growth rate equal to the 5-year average of the 10-year government bond yield of 0.08%. We discount the terminal cash flows to today's value at a cost of equity of 5.4%.
Terminal Value (TV)= FCF2033 × (1 + g) ÷ (r – g) = CHF499m× (1 + 0.08%) ÷ (5.4%– 0.08%) = CHF9.3b
Present Value of Terminal Value (PVTV)= TV / (1 + r)10= CHF9.3b÷ ( 1 + 5.4%)10= CHF5.5b
The total value, or equity value, is then the sum of the present value of the future cash flows, which in this case is CHF8.5b. The last step is to then divide the equity value by the number of shares outstanding. Relative to the current share price of CHF13.1, the company appears quite good value at a 50% discount to where the stock price trades currently. The assumptions in any calculation have a big impact on the valuation, so it is better to view this as a rough estimate, not precise down to the last cent.
The Assumptions
The calculation above is very dependent on two assumptions. The first is the discount rate and the other is the cash flows. Part of investing is coming up with your own evaluation of a company's future performance, so try the calculation yourself and check your own assumptions. The DCF also does not consider the possible cyclicality of an industry, or a company's future capital requirements, so it does not give a full picture of a company's potential performance. Given that we are looking at Clariant as potential shareholders, the cost of equity is used as the discount rate, rather than the cost of capital (or weighted average cost of capital, WACC) which accounts for debt. In this calculation we've used 5.4%, which is based on a levered beta of 1.072. Beta is a measure of a stock's volatility, compared to the market as a whole. We get our beta from the industry average beta of globally comparable companies, with an imposed limit between 0.8 and 2.0, which is a reasonable range for a stable business.
SWOT Analysis for Clariant
- Debt is not viewed as a risk.
- Dividend is low compared to the top 25% of dividend payers in the Chemicals market.
- Expected to breakeven next year.
- Has sufficient cash runway for more than 3 years based on current free cash flows.
- Good value based on P/S ratio and estimated fair value.
- Paying a dividend but company is unprofitable.
- Revenue is forecast to decrease over the next 2 years.
Moving On:
Valuation is only one side of the coin in terms of building your investment thesis, and it ideally won't be the sole piece of analysis you scrutinize for a company. The DCF model is not a perfect stock valuation tool. Instead the best use for a DCF model is to test certain assumptions and theories to see if they would lead to the company being undervalued or overvalued. For example, changes in the company's cost of equity or the risk free rate can significantly impact the valuation. Why is the intrinsic value higher than the current share price? For Clariant, there are three additional items you should further research:
- Risks: For instance, we've identified 1 warning sign for Clariant that you should be aware of.
- Future Earnings: How does CLN's growth rate compare to its peers and the wider market? Dig deeper into the analyst consensus number for the upcoming years by interacting with our free analyst growth expectation chart.
- Other Solid Businesses: Low debt, high returns on equity and good past performance are fundamental to a strong business. Why not explore our interactive list of stocks with solid business fundamentals to see if there are other companies you may not have considered!
PS. Simply Wall St updates its DCF calculation for every Swiss stock every day, so if you want to find the intrinsic value of any other stock just search here.
New: AI Stock Screener & Alerts
Our new AI Stock Screener scans the market every day to uncover opportunities.
• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies
Or build your own from over 50 metrics.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About SWX:CLN
Clariant
Engages in the development, manufacture, distribution, and sale of specialty chemicals worldwide.
Adequate balance sheet and fair value.